These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3065053)

  • 21. An open, comparative study of sulbactam plus ampicillin vs. cefotaxime as initial therapy for serious soft tissue and bone and joint infections.
    Löffler L; Bauernfeind A; Keyl W; Hoffstedt B; Piergies A; Lenz W
    Rev Infect Dis; 1986; 8 Suppl 5():S593-8. PubMed ID: 3026009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical pharmacology of antibiotics. Sulbactam/ampicillin.
    Salamone FR
    Infect Control Hosp Epidemiol; 1988 Jul; 9(7):323-7. PubMed ID: 3042857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical study on sulbactam/ampicillin in the pediatric field].
    Takeda E; Hosoda T; Ichioka T; Miyao M
    Jpn J Antibiot; 1989 Mar; 42(3):725-31. PubMed ID: 2746852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical evaluation of sulbactam/ampicillin in the pediatric infections].
    Meguro H; Arimasu O; Shiraishi H; Sugamata K; Hiruma F; Abe T; Fujii R; Mashiko J; Nagao Y; Okamoto Y
    Jpn J Antibiot; 1989 Mar; 42(3):612-22. PubMed ID: 2746845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous sulbactam/ampicillin in the treatment of pediatric infections.
    Lee CY; Lin TY; Chu ML; Lee MJ; Hsu CY; Huang LM; Chen CM
    Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):179S-183S. PubMed ID: 2686918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of sequential treatment with parenteral sulbactam/ampicillin and oral sultamicillin for skeletal infections in children.
    Aronoff SC; Scoles PV; Makley JT; Jacobs MR; Blumer JL; Kalamchi A
    Rev Infect Dis; 1986; 8 Suppl 5():S639-43. PubMed ID: 3026018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ampicillin-sulbactam monotherapy in infants with febrile urinary tract infections.
    Song JY; Yoo S; Lim TJ; Byun JH; Jo KJ; Kim HY; Park SE; Kim SH
    Pediatr Int; 2021 Apr; 63(4):430-435. PubMed ID: 32885532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ampicillin-sulbactam: an update on the use of parenteral and oral forms in bacterial infections.
    Betrosian AP; Douzinas EE
    Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1099-112. PubMed ID: 19621991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical experience with intramuscular sulbactam/ampicillin in the outpatient treatment of various infections. A multicentre trial.
    Güneren MF
    Drugs; 1988; 35 Suppl 7():57-68. PubMed ID: 3065055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of ampicillin-sulbactam for empiric treatment of ventilator-associated pneumonia in a trauma population.
    McMillian WD; Bednarik JL; Aloi JJ; Ahern JW; Crookes BA
    J Trauma; 2010 Oct; 69(4):861-5. PubMed ID: 20938272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical studies on sulbactam/ampicillin in the field of pediatrics].
    Iwata S; Yamada K; Sato Y; Ishikawa K; Akita H; Sunakawa K
    Jpn J Antibiot; 1989 Mar; 42(3):598-611. PubMed ID: 2664249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Activity of an ampicillin/sulbactam combination in respiratory infections].
    Mangiarotti P; Manara G; Grassi G; Gialdroni Grassi G
    G Ital Chemioter; 1989; 36(1-3):39-44. PubMed ID: 2488911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sultamicillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Friedel HA; Campoli-Richards DM; Goa KL
    Drugs; 1989 Apr; 37(4):491-522. PubMed ID: 2661196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of bacterial infections with sultamicillin in childhood].
    Scholz H; Märker X; Rockstroh T
    Z Arztl Fortbild (Jena); 1991 Jul; 85(13):610-4. PubMed ID: 1949980
    [No Abstract]   [Full Text] [Related]  

  • 35. [Meningitis caused by Haemophilus influenzae type B, resistant to ampicillin and chloramphenicol].
    de Juan Martín F; Aisa Iriarte ML; Boné Calvo J; Moles Calandre B
    An Esp Pediatr; 1984 Aug; 21(2):153-6. PubMed ID: 6333842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical evaluation of sulbactam/ampicillin in children].
    Ito S; Mayumi M; Ito M; Mikawa H
    Jpn J Antibiot; 1989 Mar; 42(3):675-85. PubMed ID: 2664251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical experience with treatment of childhood infections using sultamicillin--Unasyn (Pfizer)].
    Hobstová J; Havlík J
    Cesk Pediatr; 1991 Nov; 46(10-11):466-8. PubMed ID: 1786602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacokinetic, bacteriological and clinical studies of sultamicillin fine granule in pediatric field].
    Ishikawa H; Takeuchi H; Kimura H; Hayakawa F; Yamamoto N; Nakao Y; Kuno K
    Jpn J Antibiot; 1988 Dec; 41(12):1895-905. PubMed ID: 3249362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sulbactam/ampicillin in clinical practice. Proceedings of a symposium. Munich, 17 January 1987.
    Drugs; 1988; 35 Suppl 7():1-94. PubMed ID: 3220006
    [No Abstract]   [Full Text] [Related]  

  • 40. [Profile of a new antibiotic: the combination sulbactam/ampicillin].
    Barba D; Galante D; Esposito S; Giusti G
    Recenti Prog Med; 1987 Jun; 78(6):274-83. PubMed ID: 3310152
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.